Research Article

The Effectiveness of Antiviral Treatments for Patients with HBeAg-Positive Chronic Hepatitis B: A Bayesian Network Analysis

Table 3

League table presenting network meta-analysis estimates of efficacy (hazard ratio).

ALT normalization

NA
2.59 (0.70, 6.09)NA add-on PEG IFN
1.07 (0.41, 2.82)0.42 (0.11, 2.32)PEG IFN
0.55 (0.22, 1.32)0.21 (0.06, 1.07)0.51 (0.21, 1.14)PEG IFN add-on NA
1.47 (0.46, 3.22)0.56 (0.14, 2.52)1.34 (0.39, 3.54)2.64 (0.72, 7.73)PEG IFN combined NA
9.68 (2.59, 41.22)3.80 (0.84, 27.37)9.00 (1.83, 51.79)18.05 (3.64, 109.82)6.76 (1.49, 43.48)NA switch PEG IFN
2.49 (0.80, 6.49)0.95 (0.26, 4.86)2.32 (0.65, 7.42)4.59 (1.26, 15.25)1.71 (0.80, 4.32)0.26 (0.04, 1.26)PEG IFN combined PLA

HBV DNA undetectable

NA
0.59 (0.17, 2.27)NA add-on PEG IFN
1.25 (0.40, 5.05)2.09 (0.38, 13.95)PEG IFN
0.74 (0.26, 3.21)1.24 (0.25, 8.88)0.59 (0.20, 2.04)PEG IFN add-on NA
0.26 (0.07, 0.91)0.44 (0.07, 2.52)0.21 (0.04, 0.74)0.35 (0.06, 1.38)PEG IFN combined NA
21.11 (2.90, 262.11)36.56 (3.27, 567.15)17.12 (1.47, 248.25)28.69 (2.31, 404.85)82.47 (8.49, 1406.85)NA switch PEG IFN 13.49 (1.21, 236.27)
1.64 (0.37, 6.51)2.71 (0.36, 17.18)1.30 (0.20, 5.62)2.16 (0.29, 9.75)6.23 (1.91, 19.45)PEG IFN + Placebo

HBeAg loss

NA
0.52 (0.10, 2.73)NA add-on PEG IFN
0.63 (0.11, 3.29)1.21 (0.11, 11.91)PEG IFN
0.68 (0.15, 2.75)1.31 (0.14, 11.60)1.09 (0.25, 4.64)PEG IFN add-on NA
0.75 (0.10, 5.48)1.46 (0.11, 19.44)1.19 (0.09, 17.27)1.11 (0.10, 13.48)PEG IFN combined NA
0.81 (0.10, 6.95)1.57 (0.11, 22.91)1.31 (0.09, 21.36)1.19 (0.10, 16.22)1.08 (0.06, 21.17)NA switch PEG IFN
1.47 (0.08, 25.96)2.83 (0.11, 76.01)2.37 (0.08, 64.49)2.15 (0.08, 52.38)1.93 (0.26, 15.12)1.80 (0.05, 62.85)PEG IFN combined PLA

HBeAg seroconversion

NA
0.39 (0.08, 1.86)NA add-on PEG IFN
0.53 (0.13, 2.25)1.34 (0.16, 12.44)PEG IFN
0.81 (0.21, 3.14)2.09 (0.27, 16.73)1.52 (0.39, 5.86)PEG IFN add-on NA
0.55 (0.12, 2.26)1.40 (0.15, 12.65)1.04 (0.20, 4.88)0.69 (0.11, 3.79)PEG IFN combined NA
0.37 (0.04, 2.91)0.94 (0.07, 13.35)0.69 (0.05, 8.63)0.45 (0.04, 5.23)0.67 (0.05, 9.14)NA switch PEG IFN
0.62 (0.11, 3.00)1.55 (0.16, 15.37)1.17 (0.17, 7.39)0.76 (0.10, 5.06)1.12 (0.30, 4.32)1.68 (0.10, 24.88)PEG IFN combined PLA

Note: NA, nucleoside/nucleotide analogs; PEG IFN, PEG IFNylated interferon; PLA, placebo